CD40 and infection: D609‐treated BMDCs exhibited a significant reduction in the mean fluorescence intensities of costimulatory molecules, including CD80, CD86, CD40 (Figure 3G), and the differences in the reduced levels of costimulatory molecules were more pronounced after infection.